MG
ORGS

Michael Gelband’s Orgenesis Inc. Common Stock ORGS Stock Holding History

Michael Gelband’s Portfolio ORGS Stock Details ORGS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-2,229
Closed -$135K – 2319
2020
Q2 		$135K Buy
+2,229
New +$135K ﹤0.01% 1596

Other funds holding ORGS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return

Michael Gelband's ORGS Position: Q3 2020 in Review

Michael Gelband sold out of Orgenesis Inc. Common Stock (ORGS) in Q3 2020, closing a stake of 2,229 shares — an estimated $135K sold.

Michael Gelband first reported a position in ORGS in Q2 2020 and held it in 1 quarter. The position peaked at $135K in Q2 2020. 39 funds tracked by Wall St. Rank hold ORGS as of Q3 2020.

  • Michael Gelband reported no remaining Orgenesis Inc. Common Stock position as of Q3 2020 after selling out during the quarter.
  • Michael Gelband sold 2,229 Orgenesis Inc. Common Stock shares in Q3 2020, an estimated $135K.
  • Michael Gelband first reported a position in Orgenesis Inc. Common Stock in Q2 2020 and held it in 1 quarter.
  • Michael Gelband's Orgenesis Inc. Common Stock position peaked at $135K in Q2 2020.
  • 39 funds tracked by Wall St. Rank held Orgenesis Inc. Common Stock as of Q3 2020.

Based on ExodusPoint Capital Management's 13F filing for Q3 2020, filed 16 Nov 2020.